185 related articles for article (PubMed ID: 28827665)
21. Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis.
Wan CK; Tse AK; Yu ZL; Zhu GY; Wang H; Fong DW
Phytomedicine; 2010 Jul; 17(8-9):702-5. PubMed ID: 20089387
[TBL] [Abstract][Full Text] [Related]
22. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
[TBL] [Abstract][Full Text] [Related]
23. Schisandrin B inhibits Th1/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes.
Chen Z; Guo M; Song G; Gao J; Zhang Y; Jing Z; Liu T; Dong C
Int Immunopharmacol; 2016 Jun; 35():257-264. PubMed ID: 27085037
[TBL] [Abstract][Full Text] [Related]
24. Schisandrin B inhibits the proliferation and invasion of glioma cells by regulating the HOTAIR-micoRNA-125a-mTOR pathway.
Jiang Y; Zhang Q; Bao J; Du C; Wang J; Tong Q; Liu C
Neuroreport; 2017 Jan; 28(2):93-100. PubMed ID: 27977512
[TBL] [Abstract][Full Text] [Related]
25. Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts.
Jin H; Wang Z; Gu Z; Wu J; Bai X; Shao Z; Miao J; Wang Q; Wang Q; Wang X
Phytother Res; 2019 Jan; 33(1):107-116. PubMed ID: 30346051
[TBL] [Abstract][Full Text] [Related]
26. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling.
Li L; Pan Q; Han W; Liu Z; Li L; Hu X
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6753-60. PubMed ID: 18006777
[TBL] [Abstract][Full Text] [Related]
27. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and associated changes in the Ca(2+)-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Phytother Res; 2009 Nov; 23(11):1592-602. PubMed ID: 19370538
[TBL] [Abstract][Full Text] [Related]
28. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
29. Schisandrin B attenuates CCl
Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
[TBL] [Abstract][Full Text] [Related]
30. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia.
Zeng KW; Zhang T; Fu H; Liu GX; Wang XM
Eur J Pharmacol; 2012 Oct; 692(1-3):29-37. PubMed ID: 22698579
[TBL] [Abstract][Full Text] [Related]
31. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
Pan G; Li T; Zeng Q; Wang X; Zhu Y
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861264
[TBL] [Abstract][Full Text] [Related]
32. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
Seebacher NA; Richardson DR; Jansson PJ
Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
[TBL] [Abstract][Full Text] [Related]
33. Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-κB pathway in mice.
Giridharan VV; Thandavarayan RA; Bhilwade HN; Ko KM; Watanabe K; Konishi T
Free Radic Res; 2012 Jan; 46(1):50-60. PubMed ID: 22059853
[TBL] [Abstract][Full Text] [Related]
34. [Schisandrin B protects against nephrotoxicity induced by cisplatin in HK-2 cells via Nrf2-ARE activation].
Li M; Jin J; Li J; Guan CW; Wang WW; Qiu YW; Huang ZY
Yao Xue Xue Bao; 2012 Nov; 47(11):1434-9. PubMed ID: 23387073
[TBL] [Abstract][Full Text] [Related]
35. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.
Giridharan VV; Thandavarayan RA; Arumugam S; Mizuno M; Nawa H; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(11):e0142483. PubMed ID: 26556721
[TBL] [Abstract][Full Text] [Related]
36. Schisandrin A and B enhance the dentate gyrus neurogenesis in mouse hippocampus.
Cai NN; Wang ZZ; Zhu XC; Jiang Y; Zhu WQ; Yang R; Zhang XM
J Chem Neuroanat; 2020 Apr; 105():101751. PubMed ID: 32027950
[TBL] [Abstract][Full Text] [Related]
37. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
[TBL] [Abstract][Full Text] [Related]
38. Schisandrin B protects human keratinocyte-derived HaCaT cells from tert-butyl hydroperoxide-induced oxidative damage through activating the Nrf2 signaling pathway.
Ding M; Shu P; Gao S; Wang F; Gao Y; Chen Y; Deng W; He G; Hu Z; Li T
Int J Mol Med; 2018 Dec; 42(6):3571-3581. PubMed ID: 30272282
[TBL] [Abstract][Full Text] [Related]
39. Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammation.
; ; . PubMed ID: 33545313
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
